These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 11332778)

  • 41. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients.
    Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN
    Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses.
    Sima N; Li R; Huang W; Xu M; Beers J; Zou J; Titus S; Ottinger EA; Marugan JJ; Xie X; Zheng W
    Orphanet J Rare Dis; 2018 Apr; 13(1):54. PubMed ID: 29631617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuronal ceroid lipofuscinosis genes, CLN2, CLN3 and CLN5 are spatially and temporally co-expressed in a developing mouse brain.
    Fabritius AL; Vesa J; Minye HM; Nakano I; Kornblum H; Peltonen L
    Exp Mol Pathol; 2014 Dec; 97(3):484-91. PubMed ID: 25303899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis.
    Sleat DE; Donnelly RJ; Lackland H; Liu CG; Sohar I; Pullarkat RK; Lobel P
    Science; 1997 Sep; 277(5333):1802-5. PubMed ID: 9295267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The intracellular location and function of proteins of neuronal ceroid lipofuscinoses.
    Ezaki J; Kominami E
    Brain Pathol; 2004 Jan; 14(1):77-85. PubMed ID: 14997940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic markers linked to neuronal ceroid lipofuscinosis in English setter dogs.
    Lingaas F; Aarskaug T; Sletten M; Bjerkås I; Grimholt U; Moe L; Juneja RK; Wilton AN; Galibert F; Holmes NG; Dolf G
    Anim Genet; 1998 Oct; 29(5):371-6. PubMed ID: 9800325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pre- and postnatal diagnosis of patients with CLN1 and CLN2 by assay of palmitoyl-protein thioesterase and tripeptidyl-peptidase I activities.
    Young EP; Worthington VC; Jackson M; Winchester BG
    Eur J Paediatr Neurol; 2001; 5 Suppl A():193-6. PubMed ID: 11588996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological Effects on Ceroid Lipofuscin and Neuronal Structure in Cln3
    Brenneman DE; Pearce DA; Kovacs A; DeFrees S
    J Mol Neurosci; 2017 Sep; 63(1):100-114. PubMed ID: 28812237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prenatal testing for late infantile neuronal ceroid lipofuscinosis.
    Berry-Kravis E; Sleat DE; Sohar I; Meyer P; Donnelly R; Lobel P
    Ann Neurol; 2000 Feb; 47(2):254-7. PubMed ID: 10665500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Morphological studies on CLN2.
    Goebel HH; Kominami E; Neuen-Jacob E; Wheeler RB
    Eur J Paediatr Neurol; 2001; 5 Suppl A():203-7. PubMed ID: 11588998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neuronal ceroid lipofuscinosis (NCL, Batten's disease)].
    Ohno K
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):486-8. PubMed ID: 11032003
    [No Abstract]   [Full Text] [Related]  

  • 52. Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene.
    Hartikainen JM; Ju W; Wisniewski KE; Moroziewicz DN; Kaczmarski AL; McLendon L; Zhong D; Suarez CT; Brown WT; Zhong N
    Mol Genet Metab; 1999 Jun; 67(2):162-8. PubMed ID: 10356316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human pathology in NCL.
    Anderson GW; Goebel HH; Simonati A
    Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis.
    Awano T; Katz ML; O'Brien DP; Sohar I; Lobel P; Coates JR; Khan S; Johnson GC; Giger U; Johnson GS
    Mol Genet Metab; 2006 Nov; 89(3):254-60. PubMed ID: 16621647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mouse models of neuronal ceroid lipofuscinoses: useful pre-clinical tools to delineate disease pathophysiology and validate therapeutics.
    Shacka JJ
    Brain Res Bull; 2012 May; 88(1):43-57. PubMed ID: 22502604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency.
    Nijssen PC; Ceuterick C; van Diggelen OP; Elleder M; Martin JJ; Teepen JL; Tyynelä J; Roos RA
    Brain Pathol; 2003 Oct; 13(4):574-81. PubMed ID: 14655761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.
    Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N
    Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Batten disease: biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients.
    Sheth J; Mistri M; Bhavsar R; Pancholi D; Kamate M; Gupta N; Kabra M; Mehta S; Nampoothiri S; Thakker A; Jain V; Shah R; Sheth F
    BMC Neurol; 2018 Dec; 18(1):203. PubMed ID: 30541466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases.
    Junaid MA; Pullarkat RK
    Neurosci Lett; 1999 Apr; 264(1-3):157-60. PubMed ID: 10320038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder.
    Sleat DE; Gin RM; Sohar I; Wisniewski K; Sklower-Brooks S; Pullarkat RK; Palmer DN; Lerner TJ; Boustany RM; Uldall P; Siakotos AN; Donnelly RJ; Lobel P
    Am J Hum Genet; 1999 Jun; 64(6):1511-23. PubMed ID: 10330339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.